GE liver embolization tool cleared by FDA

Editorial Staff | November 30, 2012 | Health Imaging | Artificial Intelligence

The FDA has cleared GE Healthcare’s FlightPlan for Liver advanced imaging tool, which is designed to assist interventionalists plan liver embolization procedures by automatically identifying tumor vicinity vessels.

Using GE’s Innova Vision application, a highlighted 3D roadmap of vessels can be superimposed on the live fluoroscopic image, the company said.

The tool has been commercially available in Europe, Latin America and Asia since 2011.

Editorial Staff

Around the web

Radiology Business

Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business

‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.

Cardiovascular Business

Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE liver embolization tool cleared by FDA

Related Content

Around the web